Human stem cells successfully treat multiple sclerosis in mice
Steve Connor is the Science Editor of The Independent. He has won many awards for his journalism, including five-times winner of the prestigious British science writers’ award; the David Perlman Award of the American Geophysical Union; twice commended as specialist journalist of the year in the UK Press Awards; UK health journalist of the year and a special merit award of the European School of Oncology for his investigative journalism. He has a degree in zoology from the University of Oxford and has a special interest in genetics and medical science, human evolution and origins, climate change and the environment.
Thursday 05 June 2014
Human stem cells have been used successfully to treat multiple sclerosis in mice. The treated mice were able to walk and run around normally while untreated animals continued to be paralysed by the disease, scientists said.
The researchers believe the findings are promising enough to move to clinical trials on patients in the hope of developing effective treatments for this incurable and progressively debilitating disorder of the nervous system, which affects about 100,000 people in the UK.
The study involved injections of stem cells derived from human embryos, which were compared with stem cells from adult bone marrow, which are already being used in clinical trials for the treatment of multiple sclerosis. The embryonic stem cells significantly outperformed the bone marrow stem cells, scientists said.
The research was led by Xiaofang Wang from ImStem Biotechnology, based in Farmington, Connecticut, who said it was a surprise that the stem cells derived from adult bone marrow performed so badly in comparison to the embryonic stem cells.
Multiple sclerosis is caused by the destruction of the outer fatty, myelin sheath that surrounds and insulates individual nerve cells. The injected stem cells appear to stop the damage and help to restore nerve function, the researchers said.
The stem cells used in the study, published in the journal Stem Cell Reports, belong to a class known as mesenchymal stem cells, which normally form the tissues of the brain and spinal cord.
“Although there is currently no cure for MS, we are excited about the unique anti-disease abilities of these cells and feel that they may be well suited for the clinical treatment of multiple sclerosis,” said Robert Lanza, chief scientific officer of the Advanced Cell Technology, a Massachusetts-based biotechnology firm who collaborated in the study.
“The cells not only reduced the clinical symptoms of multiple sclerosis but prevented demyelination, which disrupts the ability of the nervous system to communicate, resulting in a wide range of symptoms in patients, including blurred vision, loss of balance, slurred speech, tremors, numbness, extreme fatigue, paralysis and blindness,” Dr Lanza said.
- 1 Nigel Farage: Me vs Russell Brand on Question Time – he's got the chest hair but where are his ideas?
- 2 Harry Potter fans can apply to the Hogwarts-inspired College of Wizardry
- 3 Jessica Chambers: 19-year-old woman 'doused with lighter fluid and burned alive' in the US
- 4 Russell Brand calls Nigel Farage 'poundshop Enoch Powell' in BBC Question Time debate
- 5 Orange Wednesdays are no more
Weather bomb in pictures: Storms cuts power for tens of thousands – and snow is on the way
Jessica Chambers: 19-year-old woman 'doused with lighter fluid and burned alive' in the US
Russell Brand calls Nigel Farage 'poundshop Enoch Powell' in BBC Question Time debate
Russell Brand was rendered speechless on Question Time by this man
Fury at Airbus after it hints the super-jumbo may be mothballed
Disgruntled RBS worker writes hilarious open letter to Russell Brand after anti-capitalist publicity stunt leaves him hungry
Shock poll shows voters believe Ukip is to the left of the Tories
Nigel Farage's approval rating hits 'record low' as popularity suffers in wake of Ukip sex scandal
Nigel Farage defends Kerry Smith 'ch***y' comment: 'If you are going for a Chinese, what do you say you’re going for?'
Ukip candidate jokes about 'shooting peasants' in racist and homophobic rant
Pakistan school attack live: Taliban kill at least 132 children in 'horrifying' massacre
£65000 - £80000 per annum: Recruitment Genius: Finance Director required to jo...
£15000 - £25000 per annum: Recruitment Genius: This is a unique opportunity fo...
£50000 per annum + 26 days holiday,pension: Ashdown Group: A highly successful...
£27000 per annum + pension + holidays: The Jenrick Group: A Quality Technician...